科拓生物：宁波顺懿计划减持公司股份不超过约790万股

Group 1 - Kato Bio announced that shareholder Ningbo Shunyi Venture Capital plans to reduce its stake by up to 7.9 million shares, representing 3% of the total shares [1] - Another shareholder, Ningbo Kehui Venture Capital, intends to reduce its holdings by up to 2.64 million shares, also 1% of the total shares [1] - Shareholder Qiao Xiangqian plans to reduce his stake by up to 2.64 million shares, which is 1% of the total shares [1] Group 2 - Kato Bio's market capitalization is currently 5 billion yuan [2] - The company's revenue composition for 2024 is entirely from the food manufacturing industry, accounting for 100% [1]